Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple sclerosis: individualized disease susceptibility and therapy response.

Biomarkers in medicine - 1 Feb 2013

Pravica Vera, Markovic Milos, Cupic Maja, Savic Emina, Popadic Dusan, Drulovic Jelena, Mostarica-Stojkovic Marija

Abstract excerpt

Multiple sclerosis (MS) is a heterogeneous disease in which diverse genetic, pathological and clinical backgrounds lead to variable therapy response. Accordingly, MS care should be tailored to address disease traits unique to each person. At the core of personalized management is the emergence of new knowledge, enabling optimized treatment and disease-modifying therapies. This overview analyzes the promise of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Disease Susceptibility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA Antigens

Share to Multiple Sclerosis

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Share to Prognosis

Source

Identifiers

PMID: 23387485
DOI: 10.2217/bmm.12.113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple sclerosis: individualized disease susceptibility and therapy response.PMID 23387485Read ↗

Multiple sclerosis: genetics, biomarkers, treatments.Semantic proximity Read ↗

Multiple sclerosis genetics--is the glass half full, or half empty?Semantic proximity Read ↗

Genetics and functional genomics of multiple sclerosis.Semantic proximity Read ↗

The genetics of multiple sclerosis: an up-to-date review.Semantic proximity Read ↗

Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved QuestionsSemantic proximity Read ↗

The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years.Semantic proximity Read ↗

Recent Advances and Future Challenges in the Genetics of Multiple SclerosisSemantic proximity Read ↗

Genetic determinants of risk and progression in multiple sclerosis.Semantic proximity Read ↗

The genetic architecture of multiple sclerosis in 2026: From susceptibility to disease progression.Semantic proximity Read ↗

Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measures.Semantic proximity Read ↗

Multiple sclerosis genetics: leaving no stone unturned.Semantic proximity Read ↗

From genes to characteristics of multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.